Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics, Pharmacodynamics,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07705035
What this trial is testing

DBC-664 in Adult Patients With Solid Tumors

Who this might be right for
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma+3 more
Duboce Biopharmaceuticals, Inc. 210
Early research (Phase 1)Study completedNCT06619392
What this trial is testing

A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects

Who this might be right for
Pain
Shandong Suncadia Medicine Co., Ltd. 44
Early research (Phase 1)Study completedNCT04005807
What this trial is testing

Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults

Who this might be right for
Healthy Volunteers
Belite Bio, Inc 40
Early research (Phase 1)Study completedNCT02534636
What this trial is testing

Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis

Who this might be right for
Healthy Subjects
Bristol-Myers Squibb 140
Testing effectiveness (Phase 2)Ended earlyNCT02584634
What this trial is testing

Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 43
Early research (Phase 1)Ended earlyNCT07016464
What this trial is testing

Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.

Who this might be right for
Healthy
reMYND 19
Testing effectiveness (Phase 2)Study completedNCT02598583
What this trial is testing

Dose-Escalation Study of ALXN1210 IV in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
PNH
Alexion Pharmaceuticals, Inc. 13
Early research (Phase 1)Study completedNCT01796366
What this trial is testing

A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 40
Early research (Phase 1)Study completedNCT00535522
What this trial is testing

A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer

Who this might be right for
Cancer
Millennium Pharmaceuticals, Inc. 56
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Early research (Phase 1)Study completedNCT01209351
What this trial is testing

Effect of Teduglutide on Gastric Emptying in Healthy Subjects

Who this might be right for
Healthy Volunteers
Shire 36
Very early researchEnded earlyNCT05517837
What this trial is testing

A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 46
Early research (Phase 1)Not Yet RecruitingNCT07516639
What this trial is testing

First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Who this might be right for
Healthy Subjects (HS)SLE (Systemic Lupus)
SUNHO（China）BioPharmaceutical CO., Ltd. 26
Early research (Phase 1)Study completedNCT01098877
What this trial is testing

First In Human Study Of Increasing Oral Doses Of PF-04634817

Who this might be right for
Healthy
Pfizer 27
Testing effectiveness (Phase 2)Ended earlyNCT03681951
What this trial is testing

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Who this might be right for
Neoplasms, Pancreatic
GlaxoSmithKline 8
Early research (Phase 1)Study completedNCT04916431
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults

Who this might be right for
Healthy Volunteers
ModernaTX, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT04417972
What this trial is testing

The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

Who this might be right for
Endometriosis
Jiangsu HengRui Medicine Co., Ltd. 179
Very early researchLooking for participantsNCT07577817
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Who this might be right for
AnemiaIron DeficienciesChronic Kidney Disease
Cajal Therapeutics Inc. 72
Early research (Phase 1)Study completedNCT02632526
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects

Who this might be right for
Healthy Male SubjectsCardiovascular Disease
AstraZeneca 96
Early research (Phase 1)Ended earlyNCT00060515
What this trial is testing

RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease

Who this might be right for
Mitochondrial Diseases
Repligen Corporation 12
Next Page